Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Author: Benzinga Insights | October 14, 2025 08:09am

Gainers

  • Astria Therapeutics (NASDAQ:ATXS) stock rose 41.0% to $11.94 during Tuesday's pre-market session. The market value of their outstanding shares is at $478.0 million.
  • SS Innovations (NASDAQ:SSII) shares moved upwards by 16.56% to $7.88. The market value of their outstanding shares is at $1.3 billion.
  • Tvardi Therapeutics (NASDAQ:TVRD) shares moved upwards by 13.6% to $7.6. The market value of their outstanding shares is at $62.7 million.
  • OSR Holdings (NASDAQ:OSRH) stock rose 12.44% to $0.63. The market value of their outstanding shares is at $12.1 million.
  • Rocket Pharmaceuticals (NASDAQ:RCKT) shares rose 12.1% to $3.89. The market value of their outstanding shares is at $374.4 million.
  • Innate Pharma (NASDAQ:IPHA) shares increased by 11.11% to $2.2. The market value of their outstanding shares is at $182.4 million.

Losers

  • ENDRA Life Sciences (NASDAQ:NDRA) shares declined by 17.5% to $6.7 during Tuesday's pre-market session. The market value of their outstanding shares is at $6.1 million.
  • Aclarion (NASDAQ:ACON) shares declined by 13.83% to $8.35. The company's market cap stands at $5.6 million.
  • Nanobiotix (NASDAQ:NBTX) shares fell 11.78% to $26.74. The market value of their outstanding shares is at $1.4 billion.
  • Reviva Pharmaceuticals (NASDAQ:RVPH) stock decreased by 11.0% to $0.56. The company's market cap stands at $60.2 million.
  • DBV Technologies (NASDAQ:DBVT) shares declined by 10.63% to $14.68. The market value of their outstanding shares is at $449.5 million.
  • Alterity Therapeutics (NASDAQ:ATHE) shares declined by 9.66% to $4.21. The company's market cap stands at $84.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACON ATHE ATXS DBVT IPHA NBTX NDRA OSRH RCKT RVPH SSII TVRD

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist